In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba

In Vitro Activity of the New Azole Isavuconazole (BAL4815) Compared with Six Other Antifungal Agents against 162 Cryptococcus neoformans Isolates from Cuba Antifungal Susceptibilities among Different Serotypes of Cryptococcus gattii and Cryptococcus neoformans In Vitro Activities of Isavuconazole and Other Antifungal Agents against Candida Bloodstream Isolates In Vitro Activities of Eight Antifungal Drugs against 55 Clinical Isolates of Fonsecaea spp In Vitro Susceptibilities of 217 Clinical Isolates of Zygomycetes to Conventional and New Antifungal Agents Activity of Posaconazole and Other Antifungal Agents against Mucorales Strains Identified by Sequencing of Internal Transcribed Spacers In Vitro Activities of Amphotericin B, Caspofungin, Itraconazole, Posaconazole, and Voriconazole against 45 Clinical Isolates of Zygomycetes: Comparison of CLSI M38-A, Sensititre YeastOne, and the Etest Combination of Amphotericin B with Flucytosine Is Active In Vitro against Flucytosine-Resistant Isolates of Cryptococcus neoformans Posaconazole Enhances the Activity of Amphotericin B against Aspergillus Hyphae In Vitro Posaconazole against Candida glabrata Isolates with Various Susceptibilities to Fluconazole